MyFinsight
Home
Blog
About
Proceeds from the
issuance of common stock,...
$42,625K
(91.91%↑ Y/Y)
Proceeds from the
issuance of common stock...
$270K
Proceeds from the
exercise of stock options...
$49K
(-85.37%↓ Y/Y)
Short-swing profit
settlement
$27K
Net cash provided by
financing activities
$42,331K
(39.22%↑ Y/Y)
Canceled cashflow
$640K
Increase in cash, cash
equivalents and restricted...
$25,499K
(41.94%↑ Y/Y)
Canceled cashflow
$16,832K
Debt issuance costs
$613K
(17.88%↑ Y/Y)
Payments on finance lease
liabilities
$27K
(-62.50%↓ Y/Y)
Stock-based compensation
expense
$5,088K
(44.87%↑ Y/Y)
Amortization of debt issuance
costs
$632K
(28.46%↑ Y/Y)
Depreciation
$271K
(-19.58%↓ Y/Y)
Allowance for credit
losses
$74K
(-22.92%↓ Y/Y)
Non-cash lease expense
$62K
(-70.48%↓ Y/Y)
Accounts receivable
-$24K
(-104.44%↓ Y/Y)
Loss on disposal of
property and equipment
-$1K
(99.15%↑ Y/Y)
Net cash used in
operating activities
-$16,609K
(-40.53%↓ Y/Y)
Net cash used in
investing activities
-$223K
(64.09%↑ Y/Y)
Canceled cashflow
$6,152K
Net loss
-$7,648K
(59.02%↑ Y/Y)
Change in fair value of
sepa, warrant and...
$6,469K
(593.06%↑ Y/Y)
Change in fair value of
contingent earnout...
-$6,406K
(-5438.33%↓ Y/Y)
Purchases of property and
equipment
$223K
(-66.26%↓ Y/Y)
Inventory, net
$1,128K
(568.05%↑ Y/Y)
Prepaid expenses and
other assets
$622K
(180.05%↑ Y/Y)
Trade payables and
accrued liabilities
-$426K
(-129.03%↓ Y/Y)
Operating lease
liabilities
-$62K
(23.46%↑ Y/Y)
Back
Back
Cash Flow
TriSalus Life Sciences, Inc. (TLSI)
TriSalus Life Sciences, Inc. (TLSI)
source: myfinsight.com